Developments in the pathology of ovarian tumours

Current Opinion in Obstetrics and Gynecology

Volumn 13, Issue 1, 2001, Pages 53-59

  Chapman, William B ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P27;

CANCER GRADING; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ENDOMETRIOSIS; METASTASIS; OVARY TUMOR; PATHOGENESIS; PATHOLOGY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; OVARIAN NEOPLASMS;

EID: 0034914795     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200102000-00008     Document Type: Review

References (48)

1. Mullerian epithelial and mesenchymal tumors - Introduction, clinical perspective, and principles of management
2. Ovarian serous borderline tumors with stromal microinvasion: A report of 21 cases
3. Serous tumors of low malignant potential with early stromal invasion (serous LMP with microinvasion)
4. Peritoneal implants of ovarian serous borderline tumors - Histologic features and prognosis
5. Micropapillary serous carcinoma of the ovary - A distinctive low grade carcinoma related to serous borderline tumors
6. Ovarian serous borderline tumors with micropapillary and cribriform patterns: A study of 40 cases and comparison with cases without these patterns
7. Ovarian serous borderline tumors: A critical review of the literature with emphasis on prognostic indicators
8. Microsatellite analysis in serous tumors of the ovary
9. Comparison of mutations of K-ras and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors
10. Overexpression of p21 (WAF1/CIP1) and MDM2 characterizes serous borderline ovarian tumors
11. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy
12. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei - A clinicopathological analysis of 22 cases supporting an origin in the appendix
13. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors - Atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinoma
14. Toward the development of a universal grading system for ovarian epithelial carcinoma - Testing of a proposed system in a series of 461 patients with uniform treatment and follow-up
15. Serous psammocarcinoma of the ovary and peritoneum
16. Screening for ovarian cancer: A pilot randomized trial
17. Screening for ovarian cancer: The preliminary experience of a familial ovarian cancer center
18. Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy
19. Early de novo ovarian carcinoma: A study of 14 cases
20. Histopathologic features of ovaries at increased risk for carcinoma: A case control analysis
21. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with non-carriers and hereditary breast ovarian cancer syndrome kindreds
22. Borderline and malignant mucinous tumors of the ovary: Histologic criteria and clinical behavior
23. Primary ovarian mucinous cystadenocarcinomas: A clinicopathologic study of 49 cases with long term follow-up
24. Endometrial carcinoma of the ovary arising in endometrial tissue in that organ
25. Malignant change in endometriosis
26. Ovarian tumors associated with atypical endometriosis
27. Ovarian atypical endometriosis: Its close association with malignant epithelial tumors
28. Ovarian endometriosis associated with ovarian carcinoma: A clinicopathological and immunohistochemical study
29. Allelotyping of endometriosis with adjacent ovarian carcinoma revealed evidence of a common lineage
30. Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: Clinico-pathologic evaluation
31. Loss of heterozygosity on chromosome 17q in epithelial ovarian tumors: Association with carcinomas with serous differentiation
32. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers
33. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors
34. Allelic imbalance and mutations of the PTEN gene in ovarian cancer
35. Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers
36. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer
37. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas
38. Cancer risk after a hospital discharge diagnosis of endometriosis
39. Possible role of ovarian epithelial inflammation in ovarian cancer
40. Expression of the cell cycle inhibitor p27 [KIP1] is a new prognostic marker associated with survival in epithelial ovarian tumors
41. Prognostic significance of p53 and p21 (WAF1/CIP1) immunoreactivity in epithelial cancers of the ovary
42. Immunoexpression of inhibin alpha subunit, inhibin/activin beta-A subunit and CD-99 in ovarian tumors
43. Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women
44. Immunohistochemical evidence supporting the appendiceal origin of Pseudomyxoma peritonei in women
45. Pseudomyxoma peritonei: The case of the proplexed primaries
46. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma
47. Coordinate expression of cytokeratin 7 and 20 defines unique subsets of carcinomas
48. Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma